S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|Orexigen Therapeutics to Host Second Quarter 2014 Financial Results Conference Call and Webcast|
|Orexigen Receives CHMP Day 180 List of Outstanding Issues|
|FDA Approves Orexigen's Diet Drug Contrave (2014/9/11)|
|Orexigen Therapeutics Reports Corporate and Financial Results for the Second Quarter Ended June 30, 2014|
|Orexigen Therapeutics to Present at the Bank of America Merrill Lynch Global Healthcare Conference|
|Takeda and Orexigen Announce FDA Approval of Contrave® (naltrexone HCI and bupropion HCI) Extended-release Tablets for Chronic Weight Management|
|Orexigen Expands NB32 Intellectual Property Portfolio With New U.S. Patent|
|Orexigen Therapeutics to Host Conference Call and Webcast At 8:30 AM Eastern Time September 11, 2014|
|TRACON Pharmaceuticals Completes $27 Million Financing and Expands Management Team and Board of Directors (2014/9/22)|
Click above to view more mutual fund data and stats for orex - Orexigen Therapeutics Inc.